Literature DB >> 1162567

The surgical management of prolapsed pedunculated submucous leiomyomas.

G G Brooks, A H Stage.   

Abstract

Prolapsed pedunculated leiomyomas of the uterus can best be managed by simple vaginal myomectomy. It is safe, easily performed and generally requires no anesthesia. The risk of complications during and after a major abdominal surgical procedure in the face of infection and anemia is eliminated. Interval hysterectomy, if indicated, may be done four to six weeks after vaginal myomectomy without incurring the additional risk of increased operative morbidity. Additional surgical procedures are not indicated if the pelvic examination remains normal. When large leiomyomas are encountered, the pedicle may not be accessible. Confronted with such a situation and continued blood loss and sepsis, we elected in three patients to replace the tumor within the endometrial cavity and close the cervix. Immediate hysterectomy was then carried out. Blood replacementd antibiotic coverage were instituted in advance of any operative procedure. Other pathologic entities must be kept in mind as a source of uterine bleeding that may be found in association with pedunculated myomas.

Entities:  

Mesh:

Year:  1975        PMID: 1162567

Source DB:  PubMed          Journal:  Surg Gynecol Obstet        ISSN: 0039-6087


  3 in total

1.  Clinical predictors of successful vaginal myomectomy for prolapsed pedunculated uterine leiomyoma

Authors:  Serdar Aydın; Hale Göksever Çelik; Mustafa Maraşlı; Rabia Zehra Bakar
Journal:  J Turk Ger Gynecol Assoc       Date:  2018-02-01

2.  Vaginal Myomectomy for Prolapsed Submucous Fibroid: It is Not Only 
About Size.

Authors:  Maryam Al-Shukri; Wadha Al-Ghafri; Hamoud Al-Dhuhli; Vaidyanathan Gowri
Journal:  Oman Med J       Date:  2019-11

3.  Hymen conservative techniques for vaginal surgery - a practical approach.

Authors:  Zaki Sleiman; Amal Ayed; Costas Christoforou; Marco Noventa; Amerigo Vitagliano; Antonio Simone Laganà; Giovanni Buzzaccarini
Journal:  Prz Menopauzalny       Date:  2022-02-11
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.